nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB/RIF Ultra, and culture in Uganda
|
Musisi, Emmanuel |
|
|
5 |
4 |
p. e345-e354 |
artikel |
2 |
Anorectal Neisseria gonorrhoeae infections in women with and without reported anal sex and sex workers in sexual health centres in the Netherlands: a retrospective cohort study
|
Visser, M |
|
|
5 |
4 |
p. e326-e334 |
artikel |
3 |
Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study
|
Pakdeerat, Sukripong |
|
|
5 |
4 |
p. e379-e389 |
artikel |
4 |
Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution
|
Kosugi, Yusuke |
|
|
5 |
4 |
p. e313 |
artikel |
5 |
Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis
|
Vaillant, Michel T |
|
|
5 |
4 |
p. e366-e378 |
artikel |
6 |
Dynamics and persistence of antimicrobial resistance genes and gut microbiome after travel
|
Shen, Cong |
|
|
5 |
4 |
p. e314 |
artikel |
7 |
Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial
|
Sewunet, Tsegaye |
|
|
5 |
4 |
p. e355-e365 |
artikel |
8 |
Emerging threats: global distribution and diversity of carbapenem resistance genes in Kluyvera intermedia
|
Monte, Daniel F M |
|
|
5 |
4 |
p. e310-e311 |
artikel |
9 |
GONE to combat onchocerciasis
|
Bagcchi, Sanjeet |
|
|
5 |
4 |
p. e315 |
artikel |
10 |
Heteroresistance is a cause of discrepant antibiotic susceptibility testing results
|
Ozturk, Tugba |
|
|
5 |
4 |
p. e312 |
artikel |
11 |
Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
|
O’Donnell, Jake S |
|
|
5 |
4 |
p. e400-e408 |
artikel |
12 |
Influenza incidence, lineages, and vaccine effectiveness estimates in Lima, Peru, 2023
|
Acevedo-Rodriguez, Juan Gonzalo |
|
|
5 |
4 |
p. e308-e309 |
artikel |
13 |
Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study
|
Moso, Michael A |
|
|
5 |
4 |
p. e317-e325 |
artikel |
14 |
Phase 2 trial of a novel tuberculosis drug launched
|
Holt, Ed |
|
|
5 |
4 |
p. e316 |
artikel |
15 |
Shoring up the foundations of pathogen surveillance
|
The Lancet Microbe, |
|
|
5 |
4 |
p. e307 |
artikel |
16 |
Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
|
Shafer, Martin M |
|
|
5 |
4 |
p. e335-e344 |
artikel |
17 |
Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional study
|
Maldonado, Natalia |
|
|
5 |
4 |
p. e390-e399 |
artikel |